179 related articles for article (PubMed ID: 38790896)
21. Biocompatible nanofibers based on extremophilic bacterial polysaccharide, Mauran from Halomonas maura.
Raveendran S; Dhandayuthapani B; Nagaoka Y; Yoshida Y; Maekawa T; Sakthi Kumar D
Carbohydr Polym; 2013 Feb; 92(2):1225-33. PubMed ID: 23399150
[TBL] [Abstract][Full Text] [Related]
22. Prodrug-based nanoparticulate drug delivery strategies for cancer therapy.
Luo C; Sun J; Sun B; He Z
Trends Pharmacol Sci; 2014 Nov; 35(11):556-66. PubMed ID: 25441774
[TBL] [Abstract][Full Text] [Related]
23. Glutathione- and pH-responsive nonporous silica prodrug nanoparticles for controlled release and cancer therapy.
Xu Z; Liu S; Kang Y; Wang M
Nanoscale; 2015 Mar; 7(13):5859-68. PubMed ID: 25757484
[TBL] [Abstract][Full Text] [Related]
24. Enhance the efficiency of 5-fluorouracil targeted delivery by using a prodrug approach as a novel strategy for prolonged circulation time and improved permeation.
Pasban S; Raissi H; Pakdel M; Farzad F
Int J Pharm; 2019 Sep; 568():118491. PubMed ID: 31276765
[TBL] [Abstract][Full Text] [Related]
25. Targeted prodrug approaches for hormone refractory prostate cancer.
Aloysius H; Hu L
Med Res Rev; 2015 May; 35(3):554-85. PubMed ID: 25529338
[TBL] [Abstract][Full Text] [Related]
26. Retroviral replicating vector-mediated gene therapy achieves long-term control of tumor recurrence and leads to durable anticancer immunity.
Hiraoka K; Inagaki A; Kato Y; Huang TT; Mitchell LA; Kamijima S; Takahashi M; Matsumoto H; Hacke K; Kruse CA; Ostertag D; Robbins JM; Gruber HE; Jolly DJ; Kasahara N
Neuro Oncol; 2017 Jul; 19(7):918-929. PubMed ID: 28387831
[TBL] [Abstract][Full Text] [Related]
27. A versatile strategy to create an active tumor-targeted chemo-photothermal therapy nanoplatform: A case of an IR-780 derivative co-assembled with camptothecin prodrug.
He W; Jiang Y; Li Q; Zhang D; Li Z; Luan Y
Acta Biomater; 2019 Jan; 84():356-366. PubMed ID: 30502480
[TBL] [Abstract][Full Text] [Related]
28. Incorporation of novel 1-alkylcarbonyloxymethyl prodrugs of 5-fluorouracil into poly(lactide-co-glycolide) nanoparticles.
McCarron PA; Hall M
Int J Pharm; 2008 Feb; 348(1-2):115-24. PubMed ID: 17709217
[TBL] [Abstract][Full Text] [Related]
29. A highly efficient non-viral process for programming mesenchymal stem cells for gene directed enzyme prodrug cancer therapy.
Ho YK; Woo JY; Tu GXE; Deng LW; Too HP
Sci Rep; 2020 Aug; 10(1):14257. PubMed ID: 32868813
[TBL] [Abstract][Full Text] [Related]
30. Toward antibody-directed enzyme prodrug therapy with the T268G mutant of human carboxypeptidase A1 and novel in vivo stable prodrugs of methotrexate.
Smith GK; Banks S; Blumenkopf TA; Cory M; Humphreys J; Laethem RM; Miller J; Moxham CP; Mullin R; Ray PH; Walton LM; Wolfe LA
J Biol Chem; 1997 Jun; 272(25):15804-16. PubMed ID: 9188478
[TBL] [Abstract][Full Text] [Related]
31. Prodrug Activation by Gold Artificial Metalloenzyme-Catalyzed Synthesis of Phenanthridinium Derivatives via Hydroamination.
Chang TC; Vong K; Yamamoto T; Tanaka K
Angew Chem Int Ed Engl; 2021 May; 60(22):12446-12454. PubMed ID: 33719151
[TBL] [Abstract][Full Text] [Related]
32. Self-Targeted Polysaccharide Prodrug Suppresses Orthotopic Hepatoma.
Li D; Xu W; Li P; Ding J; Cheng Z; Chen L; Yan L; Chen X
Mol Pharm; 2016 Dec; 13(12):4231-4235. PubMed ID: 27784155
[TBL] [Abstract][Full Text] [Related]
33. Effect of alginate microencapsulation on the catalytic efficiency and in vitro enzyme-prodrug therapeutic efficacy of cytosine deaminase and of recombinant E. coli expressing cytosine deaminase.
Funaro MG; Nemani KV; Chen Z; Bhujwalla ZM; Griswold KE; Gimi B
J Microencapsul; 2016 Feb; 33(1):64-70. PubMed ID: 26642874
[TBL] [Abstract][Full Text] [Related]
34. Redox-Sensitive Hyaluronic Acid Polymer Prodrug Nanoparticles for Enhancing Intracellular Drug Self-Delivery and Targeted Cancer Therapy.
Lu B; Xiao F; Wang Z; Wang B; Pan Z; Zhao W; Zhu Z; Zhang J
ACS Biomater Sci Eng; 2020 Jul; 6(7):4106-4115. PubMed ID: 33463311
[TBL] [Abstract][Full Text] [Related]
35. Nanoassemblies containing a fluorouracil/zidovudine glyceryl prodrug with phospholipase A2-triggered drug release for cancer treatment.
Jin Y; Yang F; Du L
Colloids Surf B Biointerfaces; 2013 Dec; 112():421-8. PubMed ID: 24036626
[TBL] [Abstract][Full Text] [Related]
36. Development of a novel imaging agent using peptide-coated gold nanoparticles toward brain glioma stem cell marker CD133.
Cho JH; Kim AR; Kim SH; Lee SJ; Chung H; Yoon MY
Acta Biomater; 2017 Jan; 47():182-192. PubMed ID: 27721007
[TBL] [Abstract][Full Text] [Related]
37. Selective activation of anticancer prodrugs by monoclonal antibody-enzyme conjugates.
Wallace PM; Senter PD
Methods Find Exp Clin Pharmacol; 1994 Sep; 16(7):505-12. PubMed ID: 7885077
[TBL] [Abstract][Full Text] [Related]
38. A novel valproic acid prodrug as an anticancer agent that enhances doxorubicin anticancer activity and protects normal cells against its toxicity in vitro and in vivo.
Tarasenko N; Cutts SM; Phillips DR; Berkovitch-Luria G; Bardugo-Nissim E; Weitman M; Nudelman A; Rephaeli A
Biochem Pharmacol; 2014 Mar; 88(2):158-68. PubMed ID: 24463168
[TBL] [Abstract][Full Text] [Related]
39. Zwitterion-Driven Shape Program of Prodrug Nanoassemblies with High Stability, High Tumor Accumulation, and High Antitumor Activity.
Li G; Sun B; Zheng S; Xu L; Tao W; Zhao D; Yu J; Fu S; Zhang X; Zhang H; Zhai Y; Luo C; Ding H; He Z; Sun J
Adv Healthc Mater; 2021 Dec; 10(23):e2101407. PubMed ID: 34601824
[TBL] [Abstract][Full Text] [Related]
40. Ratiometric co-delivery of doxorubicin and paclitaxel prodrug by remote-loading liposomes for the treatment of triple-negative breast cancer.
Wang Y; Chen L; Zhang Z; Liu W; Li L
Drug Deliv Transl Res; 2022 Oct; 12(10):2537-2549. PubMed ID: 35043372
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
